← Leaderboards
Kenneth W. Mahaffey
Stanford University
$4,469,466
Attributed
$17,088,468
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2019–25$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,088,468 · 4
By mechanism
UH3$7,780,995 · 1
R33$6,355,802 · 1
R61$1,532,491 · 1
UG3$1,419,180 · 1
Top collaborators
- Ronald L Dalman5 shared
- Emir Festic5 shared
- Ognjen Gajic5 shared
- Joseph Eric Levitt5 shared
- Ying Lu5 shared
- Michael A. Matthay5 shared
Most similar at Stanford University
Same institution · by research overlap
- Manisha Desai$11,620,409
- Ronald L Dalman$12,105,627
- Joseph Eric Levitt$2,511,403
- Emir Festic$1,840,035
- David A. Benaron$15,666,167
Others in their field
Other Emerging Leaders on “Treatment Effect”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$84,871,609
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Susan Abushakra · Alzheon, Inc.$47,265,244
Research focus
Treatment EffectPharmaceutical PreparationsRandomizedPlacebosCessation Of LifeClinical TrialsDisease ProgressionPreventResponseRisk ReductionAdrenal Cortex HormonesAcute Respiratory FailureAmericanAnalysis Of VarianceAlveolarActive MethodBudesonideBiological ProcessAerosolizedAortic AneurysmAgonistBiologicalBiological MarkersAccident And Emergency Department
Grant awards (10)
The LIMIting AAA with meTformin (LIMIT) Trial$1,321,656
R33 · FY2025 · HL
The LIMIting AAA with meTformin (LIMIT) Trial$1,576,678
R33 · FY2024 · HL
The LIMIting AAA with meTformin (LIMIT) Trial$1,728,178
R33 · FY2023 · HL
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)$1,581,887
UH3 · FY2023 · HL
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)$2,068,764
UH3 · FY2022 · HL
The LIMIting AAA with meTformin (LIMIT) Trial$1,729,290
R33 · FY2022 · HL
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)$2,064,826
UH3 · FY2021 · HL
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)$2,065,518
UH3 · FY2020 · HL
The LIMIting AAA with meTformin (LIMIT) Trial$1,532,491
R61 · FY2020 · HL
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)$1,419,180
UG3 · FY2019 · HL